Home
Search:
1146 feeds
357 categories
2500 articles (<24 hours)
25 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsPharmaMar announces that it has received payment of $100 million from Jazz Pharmaceuticals for the approval of ZepzelcaTM (lurbinectedin) in the U.S.
(WorldNews Belgium)

 
 

29 june 2020 14:57:14

 
PharmaMar announces that it has received payment of $100 million from Jazz Pharmaceuticals for the approval of ZepzelcaTM (lurbinectedin) in the U.S.
(WorldNews Belgium)
 


PharmaMar announces that it has received payment of $100 million from Jazz Pharmaceuticals for the approval of ZepzelcaTM (lurbinectedin) in the U.S.  PharmaMar could receive up to an additional US $150 million when full approval is achieved.  On June 15th, 2020 lurbinectedin was approved by the FDA for the treatment of adult patients with metastatic Small Cell Lung Cancer (SCLC) with disease progression.  Jazz Pharmaceuticals to launch lurbinectedin in the U.S. in July. Madrid, June 29th, 2020.- PharmaMar (MSE:PHM) has today announced that it has received payment of $100 million from Jazz Pharmaceuticals, corresponding to the first part of the regulatory milestones, for the approval of...


 
44 viewsCategory: General > Europe > Belgium
 
PharmaMar announces that lurbinectedin has received acceptance for its clinical trial application in China
(WorldNews Belgium)
Hurray for 3 rAVe Readers` Choice Awards 2020
(WorldNews Belgium)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten